Preprocedural detailed characterization of premature ventricular complexes before ablation, currently limited to the 12-lead electrocardiogram, may aid in planning and improve procedural outcomes. This article summarizes current published data on feasibility, accuracy, and impact on clinical outcomes of a novel, three-dimensional, noninvasive, single-beat mapping system (ECVUE, CardioInsight). ECVUE technology offers premature ventricular complex characterization and localization with clinically relevant accuracy and performance superior to the surface electrocardiogram. With its noninvasive and single beat advantages, ECVUE has the potential to simplify mapping, and reduce ablation and procedural time.